Company
Oasmia Pharmaceutical AB (0001607245)
Standardized SEC financial data for Oasmia Pharmaceutical AB — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001607245 · Pharmaceutical Preparations.
Net margin
-1000.0%
Return on equity
-34.2%
Ratios for fiscal year 2018, standardized from SEC filings.
Income statement
| USD | FY2017 | FY2018 |
|---|---|---|
| Revenue | $172K | $3.2M |
| R&D expense | $97.9M | $65.5M |
| Interest expense | $13.5M | $12.3M |
| Net income | -$160.2M | -$118.0M |
Standardized from Oasmia Pharmaceutical AB's SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2017 | FY2018 |
|---|---|---|
| Total assets | $521.6M | $568.1M |
| Total liabilities | $221.2M | $223.0M |
| Retained earnings | -$786.9M | -$904.9M |
| Total equity | $300.4M |
Get 0001607245 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001607245/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001607245/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"